CNC Stock Recent News

Centene's business transformation and strategic focus on core segments have led to increased operational marginality, despite losing 3.3 million Medicaid customers in 2024. I assign a "Buy" rating to Centene, with a fair valuation of $73 per share, indicating a 27% potential increase from the current price. The company's competitive advantage lies in its focus on Medicaid and Medicare, but it faces risks from regulatory changes and strong competition.

The $25,000 contribution will fund the pre-nursing pathway program for students HONOLULU , March 24, 2025 /PRNewswire/ --  'Ohana Health Plan , a leading provider of government-sponsored managed care services in Hawaiʻi and a Centene Corporation  company (NYSE: CNC), announced today a $25,000 contribution to the University of Hawaii Foundation for the 'Ohana Health Plan Pre-Nursing Scholarship at the University of Hawaiʻi West Oʻahu. The purpose of the ʻOhana Health Plan Pre-Nursing Scholarship - UH West Oʻahu  is to assist students enrolled in the pre-nursing program  at UH West O'ahu, with funds to be used for costs associated with attendance (e.g.

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Investors should keep an eye on stocks like Air Canada, Enerflex, AutoNation, Centene and CVS Health for high returns.

ST. LOUIS , March 18, 2025 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 first quarter financial results at approximately 6:00 a.m. ET on Friday, April 25, 2025, and host a conference call at 8:30 a.m.

CNC's Meridian Health Plan wins a D-SNP contract in Illinois, expanding enhanced managed care for Medicare-Medicaid-eligible individuals. The deal is likely to boost Centene's foothold and membership base in the state.

Centene Corporation is a buy opportunity under $60, with a strong valuation and momentum, despite market volatility and economic concerns. The company reported strong Q4 '24 results, with EPS of $0.80 and FY '24 EPS of $7.17, and management raised 2025 revenue guidance by $4 billion. Risks include potential Medicaid and Medicare enrollment cuts, program pullbacks, and cash flow concerns for the company, but we expect management to navigate these challenges.

ST. LOUIS , March 17, 2025 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that its subsidiary, Meridian Health Plan of Illinois, Inc. (Meridian), has been selected by the Illinois Department of Healthcare and Family Services (HFS) to continue providing Medicare and Medicaid services for dually eligible Illinoisans through a Fully Integrated Dual Eligible Special Needs Plan (D-SNP). The D-SNP program will provide services and support statewide for dually eligible members who qualify for Medicare and Medicaid, as well as dually eligible Managed Long Term Services and Supports (MLTSS) members, under a single managed care organization.

ST. LOUIS , March 7, 2025 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today it will present via webcast at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2025, at 2:30 p.m. EDT. The live webcast will be available here: Centene's Presentation.

Centene (CNC) reported earnings 30 days ago. What's next for the stock?